openPR Logo
Press release

Trigeminal Neuralgia - Drug Pipeline Landscape, 2022

08-04-2022 10:05 AM CET | Health & Medicine

Press release from: Global Insight Services

Trigeminal Neuralgia - Drug Pipeline Landscape

Trigeminal Neuralgia - Drug Pipeline Landscape

Trigeminal Neuralgia (TN), also known as tic douloureux, is a condition that causes painful sensations similar to an electric shock on one side of the face. The pain typically involves the lower face and jaw, although sometimes it affects the area around the nose and above the eye.

There are two types of TN primary and secondary. Primary trigeminal Neuralgia has been linked to the compression of the nerve. Trigeminal Neuralgia is caused by a blood vessel exerting pressure on the nerve near your brain stem. This condition can also be caused by a tumor or lesion that compresses nerves. Other known causes a swollen blood vessel or tumor that puts pressure on the nerve and multiple sclerosis.

Diagnosis of Trigeminal Neuralgia will depend on the type and location of the pain an. Doctor will first evaluate medical history and perform a physical exam. A neurological examination and magnetic resonance imaging (MRI) can also be suggested for diagnosis.

Read more about Trigeminal Neuralgia - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/trigeminal-neuralgia-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Trigeminal Neuralgia - Drug Pipeline Landscape, 2022 report provides an overview of the Trigeminal Neuralgia pipeline drugs. This report covers detailed insights on Trigeminal Neuralgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Trigeminal Neuralgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31040/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Amgen Inc
- Biogen
- Biohaven Pharmaceuticals, Inc.
- Noema Pharma AG.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31040/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trigeminal Neuralgia - Drug Pipeline Landscape, 2022 here

News-ID: 2697728 • Views: 277

More Releases from Global Insight Services

Dietary Fibres Market Is Expected Significant Growth, Forecast From 2022 to 2031 …
New York, According to a new market research report published by Global Insight Services Dietary Fibres Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Dietary fiber,
Cashew Milk Market to Show Incredible Growth and Forecast by 2031 | Daiya Foods …
New York, According to a new market research report published by Global Insight Services Cashew Milk Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Cashew milk
Casein Market 2022 Growth, Trends, Leading Players and Business Insights Forecas …
New York, According to a new market research report published by Global Insight Services Casein Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Casein is a
Cloud Encryption Market New Innovations, Challenges, Opportunities, Strategies a …
New York, According to a new market research report published by Global Insight Services Cloud Encryption Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Cloud encryption

All 5 Releases


More Releases for Neuralgia

Trigeminal Neuralgia Treatment Market Opportunity Analysis, to 2026
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. Its management must be customized
Trigeminal Neuralgia Treatment Market - Global Industry Insights, 2026
Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is also an association with collagen vascular diseases including systemic lupus erythematosus and scleroderma. The condition is treated on an outpatient basis, except till neurosurgical intervention is required. Its management must be customized
Trigeminal Neuralgia - Pipeline Review, H1 2018
"The Report Trigeminal Neuralgia - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Trigeminal Neuralgia Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2018, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581021 Trigeminal neuralgia is a chronic pain
Postherpetic Neuralgia - Pipeline Insight and Therapeutic Assessment Reviewed, 2 …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Postherpetic Neuralgia-Pipeline Insight, 2017” to its report offerings. The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265519 The report provides comprehensive insights of the ongoing therapeutic research and development across Postherpetic Neuralgia. The report provides a complete understanding of the pipeline activities covering all
Trigeminal Neuralgia Market Rugged Expansion Foreseen by 2021
Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and is more common among females. The incident represents electrical shock-like feeling and lasts from few seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic. To
Global Trigeminal Neuralgia (TN) Therapeutics Market
Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and is more common among females. The incident represents electrical shock-like feeling and lasts from few seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic.